Genprex To Expand Non-clinical Program To Study TUSC2, NPRL2
(RTTNews) - Genprex, Inc. (GNPX) Wednesday announced the expansion of its non-clinical programs into new indications to study TUSC2, the tumor sup...
Stay updated with breaking news from Material Transfer Agreements. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(RTTNews) - Genprex, Inc. (GNPX) Wednesday announced the expansion of its non-clinical programs into new indications to study TUSC2, the tumor sup...
The Cornell-led Eastern Broccoli Project, which built a broccoli industry on the East Coast worth an estimated $120 million over the last 13 years, has produced
PHOENIX, AZ / ACCESSWIRE / April 18, 2023 / Alpine 4 Holdings, Inc. (NASDAQ:ALPP), a leading operator and owner of small market businesses, announced that its subsidiaries, RCA Commercial and Elecjet,
03.04.2023 - Expect to complete patient enrollment in the randomized Phase 1/2a SIGNAL-AD Alzheimer’s study in April 2023 with topline data anticipated mid-2024 Completed enrollment of 36 patients required for a pre-planned interim analysis of KEYNOTE B84 ...
14.11.2022 - Continued Progress in Pepinemab Oncology and Neurology Clinical ProgramsPromising initial responses in Phase 1b/2 open-label KEYNOTE B84 study of pepinemab with KEYTRUDA in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patient ...